ATE550073T1 - Protein c für die wundheilung - Google Patents

Protein c für die wundheilung

Info

Publication number
ATE550073T1
ATE550073T1 AT02729651T AT02729651T ATE550073T1 AT E550073 T1 ATE550073 T1 AT E550073T1 AT 02729651 T AT02729651 T AT 02729651T AT 02729651 T AT02729651 T AT 02729651T AT E550073 T1 ATE550073 T1 AT E550073T1
Authority
AT
Austria
Prior art keywords
protein
apc
wound healing
agent
medicament
Prior art date
Application number
AT02729651T
Other languages
English (en)
Inventor
Christopher Jackson
Philip Sambrook
Original Assignee
Univ Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR5637A external-priority patent/AUPR563701A0/en
Priority claimed from AUPS1433A external-priority patent/AUPS143302A0/en
Application filed by Univ Sydney filed Critical Univ Sydney
Application granted granted Critical
Publication of ATE550073T1 publication Critical patent/ATE550073T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02729651T 2001-06-13 2002-06-11 Protein c für die wundheilung ATE550073T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR5637A AUPR563701A0 (en) 2001-06-13 2001-06-13 Treatment and composition for wound healing
AUPS1433A AUPS143302A0 (en) 2002-04-02 2002-04-02 Treatment and composition for wound healing
PCT/AU2002/000751 WO2002100445A1 (en) 2001-06-13 2002-06-11 Treatment and composition for wound healing

Publications (1)

Publication Number Publication Date
ATE550073T1 true ATE550073T1 (de) 2012-04-15

Family

ID=25646727

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02729651T ATE550073T1 (de) 2001-06-13 2002-06-11 Protein c für die wundheilung

Country Status (8)

Country Link
US (3) US20040176288A1 (de)
EP (1) EP1404412B1 (de)
JP (1) JP4351041B2 (de)
AT (1) ATE550073T1 (de)
AU (1) AU2002302192B2 (de)
CA (1) CA2450240A1 (de)
ES (1) ES2384099T3 (de)
WO (1) WO2002100445A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2358645T3 (es) 2002-09-16 2011-05-12 Agennix Incorporated Composiciones de lactoferrina y métodos de tratamiento de la úlcera diabética.
US7183381B2 (en) 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof
WO2006072137A1 (en) * 2005-01-07 2006-07-13 Northern Sydney And Central Coast Area Health Service Treatment for autoimmune and inflammatory conditions
CN104109209B (zh) * 2005-01-24 2016-06-08 得克萨斯大学体系董事会 与磷脂酰丝氨酸结合的Fc融合构建体及其治疗用途
BRPI0613227A2 (pt) * 2005-06-09 2011-01-04 Chiang Chuan Chi uma composição para cicatrização de ferida e uso desta
EP1971365A4 (de) * 2005-12-20 2010-01-13 Swiss American Products Inc Proteasezusammensetzungen zur behandlung von geschädigtem gewebe
GR1005700B (el) * 2006-09-01 2007-10-22 (40%) ����� �������� Τροπος αντιμετωπισης της 1ης φασης του εγκαυματοσσε μη σηπτικους ασθενεις με συνεχη ενδοφλεβια χορηγηση ενεργοποιημενης πρωτεινης-c για 48 ωρες με στοχο τη μειωση της τελικης εγκαυματικης βλαβης καιαυξηση της ταχυτητας επουλωσης κατα τα πρωτα επτα μετεγκαυματικα 24ωρα
AR067345A1 (es) * 2007-07-10 2009-10-07 Paion Deutschland Gmbh Uso de trombomodulina para la preparacion de un medicamento trombolitico
EP2014296A1 (de) * 2007-07-10 2009-01-14 PAION Deutschland GmbH Neuartige Strategien zur Erhöhung der Reperfusion in einem verstopften Blutgefäß
GB2457965B8 (en) * 2008-07-01 2011-02-16 Renovo Ltd Methods and systems for determining efficacy of medicaments.
US20130259854A1 (en) * 2012-04-02 2013-10-03 Saint Louis University, A Non-Profit Organization Methods and compositions for reducing the incidence of post-surgical adhesions
KR102068010B1 (ko) * 2012-07-04 2020-01-20 제트제트 바이오테크 엘엘씨 염증성 피부 질환의 치료
PT3131572T (pt) * 2014-04-16 2021-09-24 Zz Biotech Llc Análogo de apc para utilização em cicatrização de feridas
PT3137102T (pt) * 2014-04-16 2021-09-28 Zz Biotech Llc Apc para utilização no tratamento de cicatrização cutânea anormal

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571786A (en) * 1990-08-16 1996-11-05 Immuno Aktiengesellschaft Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation
US6197325B1 (en) * 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US5648380A (en) * 1991-03-01 1997-07-15 Warner-Lambert Company Anti-inflammatory wound healing compositions and methods for preparing and using same
AT397615B (de) 1991-05-14 1994-05-25 Immuno Ag Arzneimittel enthaltend protein c
US5279956A (en) * 1991-06-24 1994-01-18 The Scripps Research Institute Activated protein C polypeptides and anti-peptide antibodies, diagnostic methods and systems for inhibiting activated protein C
WO1994002172A1 (en) * 1992-07-24 1994-02-03 Oklahoma Medical Research Foundation Blockade of protein c activation reduces microvascular surgical blood loss
US5583102A (en) * 1993-12-03 1996-12-10 University Of Iowa Research Foundation Human thrombomodulin in wound healing
WO1995030429A1 (en) * 1994-05-04 1995-11-16 Board Of Trustees Of The University Of Arkansas Novel ophthalmologic uses of protein c
JP3802104B2 (ja) 1995-05-31 2006-07-26 財団法人化学及血清療法研究所 脊髄損傷に伴う神経障害の予防・治療剤
SE9600216D0 (sv) * 1996-01-18 1996-01-18 Hans Arne Hansson Styrning av läkningsprocesser
HUP0001237A3 (en) * 1997-10-20 2002-01-28 Lilly Co Eli Methods for treating vascular disorders
JP3578627B2 (ja) * 1998-05-15 2004-10-20 株式会社ホギメディカル 創傷患部の治癒を促進する組織シーラント
WO2000037022A2 (en) 1998-12-21 2000-06-29 Eli Lilly And Company Combination therapy for the treatment of sepsis
DE60144366D1 (de) 2000-02-04 2011-05-19 Scripps Research Inst Neuroprotektive, antithrombotische und anti-entzündliche anwendungen von aktiviertem protein c
US7204981B2 (en) * 2000-03-28 2007-04-17 Eli Lilly And Company Methods of treating diseases with activated protein C
EP1267915B1 (de) * 2000-03-28 2005-06-22 Eli Lilly And Company Aktiviertes protein c zur behandlung von pankreatitis

Also Published As

Publication number Publication date
US20140219991A1 (en) 2014-08-07
CA2450240A1 (en) 2002-12-19
AU2002302192B2 (en) 2007-08-16
US20040176288A1 (en) 2004-09-09
US8728512B2 (en) 2014-05-20
ES2384099T3 (es) 2012-06-29
EP1404412B1 (de) 2012-03-21
EP1404412A1 (de) 2004-04-07
EP1404412A4 (de) 2006-03-01
JP4351041B2 (ja) 2009-10-28
US20130280234A1 (en) 2013-10-24
WO2002100445A1 (en) 2002-12-19
WO2002100445A8 (en) 2006-10-26
JP2004532892A (ja) 2004-10-28

Similar Documents

Publication Publication Date Title
ATE550073T1 (de) Protein c für die wundheilung
NO20040319L (no) Sårforbinding, fremgangsmåte for fremstilling av et preparat, topisk farmasøytisk avgivelsessystem samt applikator
DE60138549D1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
DE60107819D1 (de) Verabreichungssystem für topische hautpflegemittel
DE69734661D1 (de) Foerderung der wundheilung durch chemisch modifizierte tetracycline
DE60212163D1 (de) Kontrolliertes wirkstoffabgabesystem
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
ATE336233T1 (de) Membranverabreichungssystem für wirkstoffe
BR9906477A (pt) Cicatrizante de feridas enriquecido com plaquetas aperfeiçoado
WO2004103432A3 (en) Facial masks for managing skin wounds
PT1361903E (pt) Penso para feridas
ATE339224T1 (de) Honig enthaltende pharmazeutische zusammensetzung zur wundbehandlung
DE60233891D1 (de) Selektives targeting von apoptotischen zellen
ATE474572T1 (de) Heilung von wunden
ATE241338T1 (de) Arzneistoffabgabesystem, insbesondere zur verabreichung von androgenen
ES2174533T3 (es) Uso de una mezcla de un diol y un acido alfa-hidroxi para el tratamiento de enfermedades de la piel hiperqueratoticas.
JP2004532892A5 (de)
ATE369880T1 (de) Mediziniscer verband
ES2140575T3 (es) L-lisil-glicil-l-histidina y agente terapeutico para curar heridas que lo contiene.
NO20031650D0 (no) Nye legemidler for leversykdommer
GR3031890T3 (en) Use of topically applied factor xiii for inhibiting hemorrhage.
ATE404209T1 (de) Wundheilende pharmazeutische zusammensetzung enthaltend sucralfat, glycin, aluminium acetat und vitamine
WO2004064855A8 (de) Medikament und verwendung zur tumortherapie
SE0401942D0 (sv) New antimicrobial peptide complexes
RS49796B (sr) UPOTREBA SOLI 3α, 7α-DIHIDROKSI-12-KETO-5β-HOLANSKE KISELINE KAO AKTIVNE SUPSTANCE ZA IZRADU LEKOVA ZA LEČENJE DIJABETESA